Facts & Figures

Global headquartersAubagne, France

Legal structure

Sartorius Stedim Biotech S.A. is listed on the stock exchange in Paris, France. Sartorius AG holds approximately 74% of the share capital and around 85% of the voting rights of Sartorius Stedim Biotech S.A.
Annual sales Revenue 20171,081.0 million euros
- of which EMEA43%
- of which Americas34%
- of which Asia | Pacific23%

Underlying EBITDA

Underlying EBITDA margin

294.9 million euros

27.3%

Capex ratio12,6%
Number of employees (as Dec 31, 2017)5,100

Investor Relations

Learn More

More Information

Mission

Learn More

Company Values

Learn More

Newsroom

Learn More